back to list

imap RESEARCH, A ZIMENT GROUP COMPANY, ANNOUNCES MIKE KELLY AS PRESIDENT

NEW YORK, November 8, 2004 – imap Research, a newly formed division of The Ziment Group specializing in conducting multi-client studies for the pharmaceutical and healthcare industries, announced today that it has named Mike Kelly as its President.

“I am thrilled to be joining The Ziment Group to lead this new venture,” said Kelly.

“ I believe that imap will be in a unique position to deliver superior solutions for its clients by integrating the vast resources available across the Ziment Group Companies. This combination of insight and assets available to imap on day one will be the foundation to help clients maximize the potential for their brands in today’s competitive environment.”

Kelly brings over 15 years of experience in the pharmaceutical and healthcare industries. During his career, Kelly has served in marketing, market research and sales leadership roles at Merck (NYSE:MRK), Johnson & Johnson (NYSE:JNJ) and TargetRx. Most recently, Kelly established a private consulting practice where he advised pharmaceutical and biotechnology companies on market research needs for key brands nearing launch.

“We are pleased that Mike will be the one in charge of this important initiative. He brings a wealth of talent, experience and passion to our group,” said Howard Ziment, Chief Executive Officer of The Ziment Group. “Our clients are looking more and more towards multi-client solutions when it comes to having an ongoing understanding of the therapeutic marketplaces in which their products compete. Mike and imap will deliver on this desire.”

“With resources like WebSurveyResearch and the Ziment Chronic Illness global internet panels, we will have amazing resources within The Ziment Group to drive imap,” said Kelly. “The instant access to over 75,000 physicians and 400,000 patients from around the globe will enable imap to provide fully integrated solutions. This will make our potential to satisfy clients truly limitless.”

Kelly will start at imap on December 1st and will be responsible for all aspects of the operation.

About The Ziment Group
The Ziment Group consists of Ziment, a full service consultancy offering custom marketing research for the healthcare and pharmaceutical industries worldwide; WebSurveyResearch which houses the largest dedicated panel of physicians with which to conduct marketing research through the internet; and imap Research, a division dedicated to conducting multi-client research.

The Ziment Group is the global healthcare research brand for The Kantar Group, the Information and Consultancy Division of WPP, plc. For more information on Ziment Group, go to www.zimentgroup.com.

^ Top ^